leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Winter 2013: 2013 Annual Report
 
Media > Ibogaine
May 24, 2010

ibogaine_news_id1385

New Ibogaine Study Under Development

The MAPS clinical research team met during our Psychedelic Science in the 21st Century conference to develop a new ibogaine outcome study. Principal Investigator Valerie Mojeiko and co-investigator Tom Kingsley Brown, Ph.D., will lead the new study. They will collect data from patients who undergo ibogaine treatment for opiate addiction at Pangea Biomedics in Tijuana, Mexico, in order to evaluate the long-term changes that follow ibogaine treatment. The team discussed details of the new protocol, one of which will add random urine tests as another assessment technique.

The previous ibogaine study sponsored by MAPS and led by John Harrison has ended, and we are currently evaluating the data. We are applying insights from our initial study to the design of the new protocol.



Back to Ibogaine Research

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.